Contract drug manufacturer Catalent Inc <a href="https://www.reuters.com/companies/CTLT.N" target="_blank">(CTLT.N)</a> on Friday warned that slow production at three of its facilities will impact its fiscal 2023 results and said CFO Thomas Castellano has steā¦